CURRENT ISSUE Current Issue Cover
VOL 10 NO 5 • JULY 2019
IN THIS ISSUE

Improvements in Advance Care Planning Can Translate to Patient Comfort

Pamela Hallquist Viale, RN, MS, CNS, ANP

Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without B...

Andrew Garcia,(1) PharmD, Corey Frahm,(1) PharmD, Joanne M. Jeter,(2) MD, Ivo Abraham,(1) PhD, RN, Setsuko K. Chambers,(3) MD, Janiel M. Cragun,(3) MD, and Ali McBride,(1) PharmD

A Support Intervention for Family Caregivers of Advanced Cancer Patients

Betty Ferrell,(1) PhD, RN, MA, FAAN, FPCN, CHPN, Kate Kravits,(1) MA, RN, HNB-BS, LPC, NCC, ATR-BC, Tami Borneman,(1) RN, MSN, CNS, FPCN, Sumanta K. Pal,(1) MD, and Janet Lee,(2) EdM

The Integration of Survivorship Care Planning at a Comprehensive Cancer Center

Elizabeth B. McGrath, DNP, APRN, AGACNP-BC, AOCNP®, ACHPN, Anna Schaal, MSN, APRN, and Claire Pace, MSN, APRN

 
Section Seperator

TODAY'S NEWS

Mortality Risk for Patients With Preexis...

A new population-based study showed that novel ora...

Pooled Analysis of 4-Year Survival With ...

In an analysis reported in The Lancet Oncology, An...

Surgical Resection Among Patients Receiv...

In an Italian prospective cohort study reported in...

Does Exercise Improve Outcomes in Patien...

Patients with metastatic colorectal cancer who eng...

FDA OCE and Syapse Announce Research Col...

Syapse and the U.S. Food and Drug Administration (...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Immunoglobulin Light-Chain Amyloidosis

Systemic immunoglobulin light-chain (AL) amyloidosis is a rare disorder arising from a plasma cell clone...

Dosing Schedule for Metastatic RCC with Sunitinib

An estimated 73,820 patients in the United States will be diagnosed with renal cell carcinoma...

Ivosidenib: IDH1 Inhibitor for the Treatment of AML

Acute myeloid leukemia is a hematologic malignancy originating from abnormal proliferation of...

Apalutamide for Nonmetastatic Prostate Cancer

Prostate cancer is a male-specific oncologic disease that is one of the top four leading causes of cancer in the U.S...

JADPRO Supplement: CAR T-Cell Therapy

Chimeric antigen receptor (CAR) T-cell therapy represents an exciting innovation in the treatment of cancer...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

FDA Approves Fedratinib for Myelofibrosi...

Today, the U.S. Food and Drug Administration (FDA)...

FDA Pipeline: Designation in CLL, New Dr...

Recently, the U.S. Food and Drug Administration gr...

Single-Institution Study of Next-Generat...

In a single-institution retrospective study report...

Circulating Tumor DNA and Relapse in Ear...

In a study reported in JAMA Oncology, Garcia-Muril...

Relapse of Nonseminomatous Germ Cell Tum...

In a single-institution study reported in the Jour...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.